| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/10/2008 | WO2007129219A3 Polymorphisms in growth hormone receptor, ghrelin, leptin, neuropeptide y, and uncoupling protein 2 genes and their associations with measures of performance and carcass merit in beef cattle |
| 04/10/2008 | WO2007127428A8 Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery |
| 04/10/2008 | WO2007125244A3 New detector probe acting by molecular recognition |
| 04/10/2008 | WO2007110628A3 Compositions and methods for therapy of cystic fibrosis |
| 04/10/2008 | WO2007103523A9 Antioxidant protein, compositions, and methods of use |
| 04/10/2008 | WO2007102006A3 Non-cloning vector method for generating genomic templates for cluster formation and sbs sequencing |
| 04/10/2008 | WO2007101678A3 Methods for increasing shoot-to-root ratio, seed production and resistance to diseases |
| 04/10/2008 | WO2007100833A3 Gpat4 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase |
| 04/10/2008 | WO2007099462A3 Recombinant pichia pastoris strains and process for the production of recombinant human interferon alpha |
| 04/10/2008 | WO2007097778A3 Novel restriction endonucleases, dna encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity |
| 04/10/2008 | WO2007096382A3 Method for production of a transformed cell |
| 04/10/2008 | WO2007092934A3 Methods and compositions for modifying plant biosynthetic pathways |
| 04/10/2008 | WO2007081486A3 Oral administration of defensins to treat intestinal diseases |
| 04/10/2008 | WO2007070392A3 Adenoviral expression vectors having an expression cassette in the e1 region and an inactivated e2b polymerase |
| 04/10/2008 | WO2007062795A3 Bacterial vaccine against bacterial infective agents, to be used in animals |
| 04/10/2008 | WO2007028121A9 Eg8798 and eg9703 polynucleotides and uses thereof |
| 04/10/2008 | WO2005007875A3 Enhanced promoters for synthesis of small hairpin rna |
| 04/10/2008 | US20080086788 Plastid rRNA operon promoter elements for construction of chimeric promoters for transgene expression |
| 04/10/2008 | US20080086787 Expression vector comprising nucleotide sequences coding prephanate dehydrogenase and chorismate mutase for enhancing tocopherol expression in plants |
| 04/10/2008 | US20080086786 Use of polypeptide derived from a pa1b legume albumen as insecticide |
| 04/10/2008 | US20080086785 Expression vector comprising nucleotide sequences coding polypeptides which confer salt resistance to plants |
| 04/10/2008 | US20080086783 Expression vector comprising fertility controlling elements for use as tool in generation of disease, insects, heat and drought tolerant plants |
| 04/10/2008 | US20080086002 siRNA targeting secreted frizzled-related protein 1 (sFRP1) |
| 04/10/2008 | US20080086001 siRNA targeting intercellular adhesion molecule 1 (ICAM1) |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085999 Modulation of gene expression using dna-rna hybrids |
| 04/10/2008 | US20080085998 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 04/10/2008 | US20080085997 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 04/10/2008 | US20080085996 Expression vector controlling segregation of transgene in plants |
| 04/10/2008 | US20080085995 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/10/2008 | US20080085870 Isolated polynucleotides comprising a nucleic acid which operably encodes 50 contiguous amino acids, nucleic acids are fragments of a codon-optimized coding region; a carrier |
| 04/10/2008 | US20080085869 Sense strand, antisense strand having complementarity to both the sense strand and a target gene, forming a duplex, a conjugate, facilitating cellular delivery, and a linker molecule; facilitates delivery to a cell, tissue or organism |
| 04/10/2008 | US20080085868 Non-infectious nucleic acid construct encoding a recombinant antibody to that agent; injection of a nucleic acid construct, in the form of a plasmid, encoding a virus-neutralising single chain antibody fragment mediates in vivo expression of antibodies; protecting an animal against exposure to a virus |
| 04/10/2008 | US20080085862 Natriuretic peptide conjugate using carrier substance |
| 04/10/2008 | US20080085861 Gas1 polypeptides |
| 04/10/2008 | US20080085859 Drug Promoting Ceramide Transport, Base Sequence for Producing the Drug, Method of Measuring Activity of Promoting Ceramide Release and Method of Measuring Activity of Promoting Intermembrane Ceramide Transfer |
| 04/10/2008 | US20080085854 Fusion proteins of protease inhibitors are provided, in particular fusion proteins of alpha 1-antitrypsin (AAT) and a second protease inhibitor, such as secretory leukocyte protease inhibitor (SLPI) or tissue inhibitor of metalloproteases (TIMP). Polynucleotides encoding the fusion proteins, vectors |
| 04/10/2008 | US20080085853 nuclear delivery construct comprises (i) protein H or a fragment or derivative thereof that is capable of being targeted to the nucleus of a eukaryotic cell; |
| 04/10/2008 | US20080085837 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 04/10/2008 | US20080085835 Rps gene family, primers, probes and detection methods |
| 04/10/2008 | US20080085558 Process for Chromosomal Integration and DNA Sequence Replacement in Clostridia |
| 04/10/2008 | US20080085557 Human Cancer Stem Cell Culture Compositions Comprising Erbb2 Variants and Methods of use Thereof |
| 04/10/2008 | US20080085553 Dna modular cloning vector plasmids and methods for their use |
| 04/10/2008 | US20080085545 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/10/2008 | US20080085540 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 04/10/2008 | US20080085539 Expression vector comprising yeast secretory leader sequence, biotin acceptor site for golgi-localized biotin ligase and yeast replication origin for use as tool in expression of heterologous gene sequences in yeast cells |
| 04/10/2008 | US20080085537 Expression vector comprising nucleotide sequences coding multicistronic transcription unit and selectable marker polypeptide under translational control of a down stream internal ribosome entry site (IRES) for use in enhancement of heterologous gene expression |
| 04/10/2008 | US20080085535 Using gene transfer construct comprising site specific integration sites as tool in enhancement of cell transformation and heterologous gene expression |
| 04/10/2008 | US20080085531 Antagonistic anti-human CD40 monoclonal antibody |
| 04/10/2008 | US20080085517 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 04/10/2008 | US20080085509 Single copy genomic hybridization probes and method of generating same |
| 04/10/2008 | US20080085279 Murine double mutant binding protein (MTBP) inhibitor for use as tool in treatment and prevention of cell proliferative disorders |
| 04/10/2008 | US20080085273 Vehicle for the transport of a chosen molecule to a cell |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | US20080085241 highly selective; tumor-specific binding proteins; amino acid sequence; nucleic acid molecule; recombinant expression vector; host cell; cancer diagnosis; identify only those markers recognized by the human immune system as sufficiently foreign to trigger the production of antibodies; antigen is CD98hc |
| 04/10/2008 | US20080083406 Heat resistant termamyl-like hydrolase for use in detergents, textile treatment and industrial starch processing |
| 04/10/2008 | DE10066235B4 Targeted inhibition of gene expression by administration of double stranded oligoribonucleotide to a cell, useful for treating humans, animals and plants against viral infection |
| 04/10/2008 | CA2847007A1 Process for the production of polyunsaturated fatty acids in transgenic organisms |
| 04/10/2008 | CA2665403A1 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof |
| 04/10/2008 | CA2665351A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | CA2665336A1 Process for the production of polyunsaturated fatty acids in transgenic organisms |
| 04/10/2008 | CA2665332A1 High yield production of sialic acid (neu5ac) by fermentation |
| 04/10/2008 | CA2665286A1 Process for the production of recombinant proteins using carnivorous plants |
| 04/10/2008 | CA2665202A1 Compounds and methods |
| 04/10/2008 | CA2665120A1 Process for chromosomal integration and dna sequence replacement in clostridia |
| 04/10/2008 | CA2664938A1 Method for obtaining variants of lactic bacteria useful in the production of k2 vitamin and applications for the preparation of food products |
| 04/10/2008 | CA2664738A1 Compositions and methods for diagnosing and treating cancer |
| 04/10/2008 | CA2664701A1 Cloning, expression and use of acid phospholipases |
| 04/10/2008 | CA2664696A1 Stabilizing compositions and methods for extraction of ribonucleic acid |
| 04/10/2008 | CA2664356A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 04/10/2008 | CA2658618A1 Novel gene disruptions, compositions and methods relating thereto |
| 04/10/2008 | CA2635613A1 High throughput screening methods for anti-metastatic compounds |
| 04/09/2008 | EP1908851A2 Genetic analysis for stratification of cancer risk |
| 04/09/2008 | EP1908849A1 Hybridization detection method |
| 04/09/2008 | EP1908844A1 Use of pol III promoters for controlled expression of therapeutic proteins |
| 04/09/2008 | EP1908843A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 04/09/2008 | EP1908842A2 PEF-TU expression units |
| 04/09/2008 | EP1908841A1 Multiple promoters and their use for gene expression |
| 04/09/2008 | EP1908840A1 Process for chromosomal integration and DNA sequence replacement in clostridia |
| 04/09/2008 | EP1908839A2 Virulence genes, proteins, and their use |
| 04/09/2008 | EP1908838A2 Isolation and characterisation of the csb3-1 mutant of arabidopsis thaliana and use thereof as a regulator of resistance in plants to diseases caused by biotrophic pathogens |
| 04/09/2008 | EP1908837A2 Human receptor proteins, related reagents and methods |
| 04/09/2008 | EP1908836A1 Novel G protein-coupled receptor proteins |
| 04/09/2008 | EP1908835A2 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 04/09/2008 | EP1908834A2 Heteromultimeric ion channel receptor and uses thereof |
| 04/09/2008 | EP1908833A1 Novel temporal gene and application of the same |
| 04/09/2008 | EP1908832A2 A method for increasing the concentration of a nucleic acid molecule |
| 04/09/2008 | EP1908831A2 Novel potassium channel |
| 04/09/2008 | EP1908830A1 Non-human gene-disrupted animal having adam11 gene disruption |
| 04/09/2008 | EP1908829A1 Oligonucleotide probe |
| 04/09/2008 | EP1908828A1 Novel polypeptide and method for producing the same |
| 04/09/2008 | EP1908827A2 Regulation of cardiac contractility and heart failure propensity |
| 04/09/2008 | EP1908826A1 Prostate cancer related protein derived peptide which is a peptide vaccine candidate for prostate cancer patients with hla-a3 supertype alleles |
| 04/09/2008 | EP1908825A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 04/09/2008 | EP1908823A1 Component of bromelain |
| 04/09/2008 | EP1908821A1 Use of mva as adjuvant in the stimulation of antigen-presenting cells |
| 04/09/2008 | EP1908780A1 Novel chimeric proteins and methods for using the same |
| 04/09/2008 | EP1908779A1 Thymosin beta 4 derivatives and use thereof |
| 04/09/2008 | EP1908777A1 Mite fusion proteins |
| 04/09/2008 | EP1908776A1 Mite fusion proteins |